PERSPECTA

News from every angle

← Back to headlines

Novo Nordisk’s Higher Dose Wegovy Weight-Loss Drug Gains U.S. Approval - WSJ

Novo Nordisk’s Higher Dose Wegovy Weight-Loss Drug Gains U.S. Approval  WSJ

19 Mar, 18:19 — 19 Mar, 18:19
PostShare

Sources

Showing 1 of 1 sources
wsjHigh20d ago

Novo Nordisk’s Higher Dose Wegovy Weight-Loss Drug Gains U.S. Approval - WSJ

Novo Nordisk’s Higher Dose Wegovy Weight-Loss Drug Gains U.S. Approval  WSJ

Read full article →

Related Stories

Manila Water prepares for summer heat and high demand

just now

Ozempic Patent Expiration Leads to Flood of Generics and Abuse Concerns in Asia

24m ago

Measles Outbreak Spreads from Rural to Urban Utah

37m ago

Philippines Announces Results of April 2026 Physicians Licensure Examination

39m ago